# Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

> **NCT01259726** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 173 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **BIOLOGICAL:** VP20621
- **BIOLOGICAL:** VP20621
- **OTHER:** Placebo
- **BIOLOGICAL:** VP20621

## Key facts

- **NCT ID:** NCT01259726
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-27
- **Primary completion:** 2013-06-11
- **Final completion:** 2013-06-11
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259726, "Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01259726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*